All patients’ tissue biopsy samples were examined to check the expressions of the estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and the Ki67 (MKI67) value (Table 1), and two patients belonged to the triple-negative breast cancer (TNBC) group. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.